Regenerative Medicine and Barriers to Commercialisation Online Summit 2011

The regenerative medicine industry is worth an estimated $500bn yet the rate of approval and therapies coming onto the market is slow, so how are you overcoming the barriers to commercialisation? PharmaIQ's Regenerative Medicine Online Summit brings together the global community of biotech, pharma and academic experts along with government representatives, IP sepecialits, VCs and many more to discuss this complex landscape, share case studies and develop strategies to drive innovation and speed time to market